Franz Blaes
Overview
Explore the profile of Franz Blaes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muck A, Pfeuffer S, Mir L, Genau S, Emde J, Olbricht L, et al.
J Neurol
. 2024 Jun;
271(8):5650-5655.
PMID: 38839637
No abstract available.
2.
Stascheit F, Grittner U, Hoffmann S, Mergenthaler P, Schroeter M, Ruck T, et al.
J Neurol
. 2022 Sep;
270(1):1-12.
PMID: 36166068
Background: Patients with myasthenia gravis (MG) are potentially prone for a severe COVID-19 course, but there are limited real-world data available on the risk associated with COVID-19 for patients with...
3.
Dharmalingam B, Singh P, Schramm P, Birklein F, Kaps M, Lips K, et al.
Pain
. 2022 Apr;
163(12):2446-2456.
PMID: 35384930
Complex regional pain syndrome (CRPS) is an inadequate local response after a limb trauma, which leads to severe pain and autonomic and trophic changes of the affected limb. Autoantibodies directed...
4.
Blaes F
Expert Rev Neurother
. 2021 May;
21(6):675-686.
PMID: 33960258
: Paraneoplastic neurological syndromes (PNS) are a rare heterogeneous group of neurological diseases associated with tumors. These syndromes are the result of a cross-reactive immune response against antigens shared by...
5.
Schroeter M, Berger B, Blaes F, Hagenacker T, Jander S, Kaiser J, et al.
J Cent Nerv Syst Dis
. 2021 Feb;
13:1179573521989151.
PMID: 33597816
Background And Purpose: In 2017, eculizumab has been approved for treatment-refractory generalised myasthenia gravis (TRgMG). The German Myasthenia Foundation has published a consensus statement on the use of eculizumab, with...
6.
Zar T, Tschernatsch M, Hero B, Lang B, Preissner K, Blaes F
J Pediatr Hematol Oncol
. 2020 Oct;
43(2):e176-e179.
PMID: 33060390
Pediatric opsoclonus-myoclonussyndrome (OMS) is a rare autoimmune disorder of which 50% are associated with neuroblastoma (NB). We investigated whether surface-binding autoantibodies in OMS can enhance natural killer (NK) cell-mediated cytotoxicity...
7.
BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases
Braun T, Juenemann M, Dornes K, El-Shazly J, Schramm P, Bick-Ackerschott S, et al.
Int J Neurosci
. 2020 Jul;
131(12):1231-1236.
PMID: 32602764
Purpose: Multiple sclerosis (MS) is the most common immune-mediated CNS disease, characterised by demyelination and progressive neurological disability. The B-cell activating factor BAFF has been described as one important factor...
8.
Juenemann M, Nef H, Mollmann H, Singh P, Troidl C, Schramm P, et al.
Immunobiology
. 2018 Dec;
224(2):220-222.
PMID: 30554740
Background: An association between Tako-Tsubo cardiomyopathy (TTC) and underlying malignancies has been observed, suggesting that TTC might be the consequence of paraneoplastic phenomena. This study investigates the presence of autoantibodies...
9.
Tackenberg B, Schneider M, Blaes F, Eienbroker C, Schade-Brittinger C, Wellek A, et al.
EBioMedicine
. 2018 Jan;
28:143-150.
PMID: 29337134
Background: It is a continuous matter of discussion whether immune activation by vaccination in general and Influenza vaccination in particular increases the risk for clinical deterioration of autoimmune diseases. This...
10.
Mitchell W, Blaes F
Semin Pediatr Neurol
. 2017 Nov;
24(3):180-188.
PMID: 29103425
Cancer and autoimmunity come together in paraneoplastic syndromes (PNS), which reflect the remote, not direct, effects of cancer. In the pediatric population, a variety of PNS have been described, but...